47 reports

The Global Human Growth Hormone Market size is expected to reach $7.1 billion by 2025, rising at a market growth of 8.3% CAGR during the forecast period. Human growth hormone (HGH), also referred to as somatotropin, is a peptide hormone that stimulates growth, helps in cell reproduction as well as regeneration in humans. It is therefore important...

  • Human Growth Hormone
  • World
  • Spain
  • Asia
  • Europe
  • APAC

‘Antibody-Mediated Rejection (AMR) – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the AMR, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The AMR market report provides current...

  • Epidemiology
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Drug Approval

“Etanercept - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the Etanercept in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

  • Biopharmaceutical
  • Spain

‘Gene and Cell Therapies targeting CNS Disorders – Market Insights and Market Forecast – 2026’ report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting CNS Disorders in in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Gene and Cell Therapies targeting...

  • Cell Therapy
  • Mental Health
  • World
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom
  • Health Expenditure

‘B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of B-cell NHL in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Geography...

  • Immunotherapy
  • Lymphoma
  • Spain
  • Germany
  • France
  • Japan
  • United States
  • Italy
  • United Kingdom
  • Stem Cell Transplantation

‘Adeno-Associated Virus (AAV) Vector Based Gene Therapy - Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the AAV Vector Based Gene Therapy, historical and forecasted epidemiology as well as the AAV Vector Based Gene Therapy market trends in the United States, EU5 (Germany, France, Italy,...

  • Gene Therapy
  • United States
  • Germany
  • Spain
  • France
  • Japan
  • Italy
  • United Kingdom
  • Medical Technology Density
  • Hospital Admission

Table ##: Pamlico Biopharma, Inc- Community Acquired Pneumonia Pipeline, H##- 2018

  • Therapy
  • Anti-Infective
  • Hormone
  • Pharmaceutical
  • Biopharmaceutical
  • Protein Therapy
  • Spain
  • World
  • United States
  • Community of Madrid
  • Mortality Rate
  • Hospital Admission

Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets (US, Japan, EU5 and BRIC); Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn Report...

  • Biopharmaceutical
  • Pharmaceutical
  • Regenerative Medicine
  • Gene Therapy
  • Monoclonal Antibody
  • Japan
  • United States
  • BRIC
  • Spain
  • China
  • France
  • Germany
  • Russia
  • India
  • Italy
  • Brazil
  • United Kingdom

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Clinical Research
  • Pancreatic Cancer
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Direct Sales
  • Manufacturing Orders

The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market...

  • Diagnostics
  • Public Health
  • Monoclonal Antibody
  • Europe
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

  • Infectious Disease
  • Diagnostics
  • Public Health
  • Monoclonal Antibody
  • Europe
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

Alerpharma wholly owns the Spanish-based allergy immunotherapy company Instituto de Immunologia y Alergia, S.A.U. (Inmunal), a spin-out from a biopharmaceutical company, Zeltia S.A.Alerpharma recorded unaudited turnover and pre-tax profits of approximately EUR##.## million (USD##.## million) and EUR##.## (USD##.## million) respectively in the financial year ended December ##, and its unaudited net assets as at December ## were approximately EUR##.## million (USD##.## million).

  • Allergy Immunotherapy
  • Pharmaceutical
  • Healthcare
  • United States
  • Germany
  • Europe
  • Spain
  • United Kingdom
  • Drug Approval

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

Summary Crucell NV (Crucell) is a biopharmaceutical company. It discovers, develops, manufactures and markets vaccines and antibodies indicated against infectious diseases. Its product portfolio comprises marketed products, vaccines under development and development stage antibodies. The company’s range of marketed vaccine is...

  • Pharmaceutical
  • Infectious Disease
  • Biopharmaceutical
  • Sexually Transmitted Disease
  • Healthcare
  • Research And Development
  • Influenza
  • Europe
  • APAC
  • China
  • Netherlands
  • North America
  • South Korea
  • Middle East
  • Italy
  • United Kingdom
  • Spain
  • Sweden
  • Africa
  • Switzerland

Summary Novozymes A/S (Novozymes) is a biotech company. Its core business includes industrial enzymes, microorganisms, biopolymers and biopharmaceutical ingredients. The company develops, produces and distributes enzymes for detergent, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture,...

  • Oil And Gas
  • Wastewater Treatment
  • Biopharmaceutical
  • Europe
  • APAC
  • North America
  • China
  • Japan
  • Middle East
  • United Kingdom
  • Canada
  • Spain
  • Denmark
  • Sweden
  • Austria
  • India
  • Africa
  • Brazil

Grifols S.A. (Spain)

3070 3500 2730

This report presents quick facts about Grifols S.A., which is principally involved in Specialty Biopharmaceuticals Business. Illustrated with 83 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • Spain

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom
  • United States

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom
  • United States

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Diagnostics
  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom
  • United States

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom
  • United States

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom
  • United States

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom